Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Scienture Holdings Inc. (SCNX:NASDAQ), powered by AI.
Scienture Holdings Inc. is currently trading at $0.30. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Scienture Holdings Inc. on Alpha Lenz.
Scienture Holdings Inc.'s P/E ratio is 0.1.
“Scienture Holdings Inc. trades at a P/E of 0.1 (undervalued) with strong ROE of 22.8%.”
Ask for details →Scienture Holdings Inc. is a diversified financial asset that represents a crucial player in the healthcare and biotech sectors. Its primary function revolves around advancing medical and scientific innovations, focusing on biotechnology, pharmaceuticals, and healthcare solutions. As an organization, Scienture Holdings is instrumental in driving research and development initiatives that lead to groundbreaking treatments and technologies. The entity impacts several key industries, including medical research, drug development, diagnostics, and therapeutic technologies. Its operations are essential to advancing global health outcomes and supporting the industry's growth through strategic partnerships and investments. Renowned for fostering innovation, Scienture Holdings contributes significantly to the market by enhancing the quality and accessibility of healthcare solutions, thereby playing a pivotal role in the industry's dynamic landscape.
“Scienture Holdings Inc. trades at a P/E of 0.1 (undervalued) with strong ROE of 22.8%.”
Ask for details →